2 results match your criteria: "987690 University of Nebraska Medical Center[Affiliation]"
CD95-ligand contributes to abdominal aortic aneurysm progression by modulating inflammation.
Cardiovasc Res
March 2019
Department of Surgery, 987690 University of Nebraska Medical Center, Omaha, NE, USA.
Aims: Abdominal aortic aneurysm (AAA) is one of the number of diseases associated with a prominent inflammatory cell infiltration, matrix protein degradation, and smooth muscle cell apoptosis. CD95 is an inflammatory mediator and an apoptosis inducer. Previous studies have shown elevated expression of CD95 or CD95L in the aortic tissue of AAA patients.
View Article and Find Full Text PDFProlongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48.
Clin Immunol
February 2003
Department of Surgery, University of Nebraska Medical Center, The Lied Transplant Center, 987690 University of Nebraska Medical Center, Omaha, NE 68198-7690, USA.
Ly49A receptors expressed on NK, NKT, and T cells play inhibitory roles in regulating the immune responses in vivo and in vitro. Whether or not injection of anti-Ly49A monoclonal antibody (mAb) YE1/48 can block allograft rejection has not been evaluated. Balb/c mouse recipients received intraperitoneal injections of YE1/48 mAb (0.
View Article and Find Full Text PDF